Mail

Is Bush science's nemesis? Sure, George Bush has joined a line of presidents who, for political gain, act contrary to the best interests of science.1,2 But a full accounting of the Bush administration shows it distinguishes itself from the others in two significant ways: 1) its ruthless political efficiency, and 2) its unwavering moral certitude. The two are tightly linked, and embryonic stem cell research bears the brunt of this holy alliance. Consider Bush's SWAT squad, rappelli

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Sure, George Bush has joined a line of presidents who, for political gain, act contrary to the best interests of science.1,2 But a full accounting of the Bush administration shows it distinguishes itself from the others in two significant ways: 1) its ruthless political efficiency, and 2) its unwavering moral certitude. The two are tightly linked, and embryonic stem cell research bears the brunt of this holy alliance. Consider Bush's SWAT squad, rappelling into the United Nations in the summer of 2004 as the members were set to vote in support of therapeutic cloning. Guerrilla tactics, including rustling up nay votes from third-world Catholic nations with problems much bigger than stem cells, scuppered the vote.

Christopher Thomas Scott
Stanford Center for Biomedical Ethics
cscott@stanford.edu

In what sense is Bush's position on embryonic stem cell research "anti-science"? In many areas of research, anyone who wants to do anything with human subjects needs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies